WHO ICTRP trial
Performances of controlled Attenuation Parameter (CAP) assessed by FIBROSCAN for…
ChiCTR-DDT-14004874 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR-DDT-14004874 |
|---|---|
| Public title | Performances of controlled Attenuation Parameter (CAP) assessed by FIBROSCAN for the screening of liver steatosis in General Population |
| Scientific title | Performances of controlled Attenuation Parameter (CAP) assessed by FIBROSCAN for the screening of li |
| Primary sponsor | Chinese PLA General Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Diagnostic test |
| Phase | IV (Phase IV study) |
| Countries | China |
| Conditions | Fatty liver disease |
| Interventions | Gold Standard:;Index test: |
| Registration date | May 30, 2014 |
| Target size | Target condition:0;Difficult condition:0 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: